cephalexin has been researched along with 7432 s in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inui, K; Mukai, M; Saito, H; Terada, T | 1 |
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Toda, T; Uchino, J | 1 |
| Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Uchino, J | 1 |
| Barry, AL; Jones, RN | 1 |
| Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
| Iseki, K; Miyazaki, K; Satoh, Y; Sugawara, M | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
1 review(s) available for cephalexin and 7432 s
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for cephalexin and 7432 s
| Article | Year |
|---|---|
Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Ceftibuten; Cephalosporins; Cyclacillin; Dipeptides; Hydrogen-Ion Concentration; Kidney; Kinetics; LLC-PK1 Cells; Peptide Transporter 1; Rats; Recombinant Proteins; Structure-Activity Relationship; Symporters; Transfection | 1997 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Transport characteristics of cephalosporin antibiotics across intestinal brush-border membrane in man, rat and rabbit.
Topics: Administration, Oral; Animals; Biological Transport; Ceftibuten; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Dipeptides; Humans; Intestinal Absorption; Microvilli; Rabbits; Rats; Species Specificity | 1992 |
Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
Topics: Biological Transport, Active; Cefixime; Cefotaxime; Ceftibuten; Cephalexin; Cephalosporins; Glucose; Humans; Hydrogen; In Vitro Techniques; Jejunum; Microvilli | 1991 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
[Effect of Enterued administration on the intestinal absorption of orally active cefem antibiotics].
Topics: Administration, Oral; Animals; Ceftibuten; Cephalexin; Cephalosporins; Drug Synergism; Enteral Nutrition; Humans; Intestinal Absorption; Intestine, Small; Male; Oligopeptides; Rats; Rats, Wistar | 1994 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |